Phase II trial of paclitaxel, 13-cis retinoic acid, and interferon-alfa-2b in the treatment of advanced stage or recurrent cervical cancer

Song, Mihae

71 - Focused Plenary
Phase II trial of paclitaxel, 13-cis retinoic acid, and interferon-alfa-2b in the treatment of advanced stage or recurrent cervical cancer

Sunday, March 23, 2014: 2:00 PM

Ballroom D (Tampa Convention Center)

M. Song¹, R. Di Paola¹, B. M. Cracchiolo², D. G. Gibbon¹, M. Hellmann¹, W. Nieves¹, A. P. Vaidya³, A. Wagreich¹, W. Shih¹ and L. Rodriguez-Rodriguez¹
¹Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, ²Rutgers New Jersey Medical School, Newark, NJ, ³John Theuerer Cancer Center, Hackensack, NJ

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

71 - Focused Plenary
Phase II trial of paclitaxel, 13-cis retinoic acid, and interferon-alfa-2b in the treatment of advanced stage or recurrent cervical cancer

71 - Focused Plenary Phase II trial of paclitaxel, 13-cis retinoic acid, and interferon-alfa-2b in the treatment of advanced stage or recurrent cervical cancer

71 - Focused Plenary
Phase II trial of paclitaxel, 13-cis retinoic acid, and interferon-alfa-2b in the treatment of advanced stage or recurrent cervical cancer